131 related articles for article (PubMed ID: 14997053)
1. c-kit and SCF expression in normal and tumor breast tissue.
Ulivi P; Zoli W; Medri L; Amadori D; Saragoni L; Barbanti F; Calistri D; Silvestrini R
Breast Cancer Res Treat; 2004 Jan; 83(1):33-42. PubMed ID: 14997053
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-kit proto-oncogene product in breast tissue.
Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA
Breast J; 2004; 10(4):323-7. PubMed ID: 15239791
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status.
Tsuura Y; Suzuki T; Honma K; Sano M
J Cancer Res Clin Oncol; 2002 May; 128(5):239-46. PubMed ID: 12029439
[TBL] [Abstract][Full Text] [Related]
4. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
6. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
[TBL] [Abstract][Full Text] [Related]
7. C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
Diallo R; Rody A; Jackisch C; Ting E; Schaefer KL; Kissler S; Karn T; Geddert H; Engels K; Kaufmann M; Gabbert HE; Shroyer KR; Poremba C
Hum Pathol; 2006 Feb; 37(2):205-11. PubMed ID: 16426921
[TBL] [Abstract][Full Text] [Related]
8. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues.
Sóñora C; Mazal D; Berois N; Buisine MP; Ubillos L; Varangot M; Barrios E; Carzoglio J; Aubert JP; Osinaga E
J Histochem Cytochem; 2006 Mar; 54(3):289-99. PubMed ID: 16148312
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
Uccini S; Mannarino O; McDowell HP; Pauser U; Vitali R; Natali PG; Altavista P; Andreano T; Coco S; Boldrini R; Bosco S; Clerico A; Cozzi D; Donfrancesco A; Inserra A; Kokai G; Losty PD; Nicotra MR; Raschellà G; Tonini GP; Dominici C
Clin Cancer Res; 2005 Jan; 11(1):380-9. PubMed ID: 15671569
[TBL] [Abstract][Full Text] [Related]
11. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
12. The expression of stem cell factor and c-kit receptor in human asthmatic airways.
Al-Muhsen SZ; Shablovsky G; Olivenstein R; Mazer B; Hamid Q
Clin Exp Allergy; 2004 Jun; 34(6):911-6. PubMed ID: 15196279
[TBL] [Abstract][Full Text] [Related]
13. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
14. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.
Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U
J Cell Physiol; 1997 Jul; 172(1):1-11. PubMed ID: 9207920
[TBL] [Abstract][Full Text] [Related]
15. Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1).
Nakatani T; Marui T; Yamamoto T; Hitora T; Akisue T; Kawamoto T; Nagira K; Fujita I; Matsumoto K; Yoshiya S; Kurosaka M
Anticancer Res; 2003; 23(3B):2329-33. PubMed ID: 12894511
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
19. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.
Tamborini E; Papini D; Mezzelani A; Riva C; Azzarelli A; Sozzi G; Pierotti MA; Pilotti S
Br J Cancer; 2001 Aug; 85(3):405-11. PubMed ID: 11487273
[TBL] [Abstract][Full Text] [Related]
20. The dermal stem cell factor and c-kit are overexpressed in melasma.
Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
